TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
OLMA

Olema Pharmaceuticals Inc

Healthcare · Biotechnology

8.80$ -3.2% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet OLMA
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– -96.0% +259,537.9% -13.6% -27.1% +28.4% +62.8% +18.3%
– -96.8% +332,071.8% -15.0% -28.1% +27.6% +64.5% +17.6%
– -97.8% +497,766.2% -95.9% +71.6% +189.2% +103.5% -65.4%
– -97.8% +497,766.2% -15.2% -28.8% +28.1% +65.8% +16.4%
– – – – +145.4% +111.0% +215.0% +91.3%
– – – – – – – –
– +0.0% +188.5% +6,193.3% -68.6% – – –
– – – – – – – –
– +12.3% -57.3% +148.1% +59.1% +27.4% +82.3% +30.6%
– +585.6% +232.7% +96.7% +83.5% +30.6% +93.1% +24.1%
– – – – +9.0% -2.7% +18.6% -4.1%
– +706.0% -23.1% -96.8% +1,526.1% +621.4% +65.3% +107.5%
– – – – – – – –
– – – -15.8% -30.6% +28.5% +61.1% +17.0%
– – – – – – – –
– +184.9% -2.1% +0.5% +1.2% +13.1% +29.8% +48.1%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?